
ApoB Blood Test Promises Better Heart-Health Guidance Than LDL
A Northwestern Medicine study in JAMA finds apoB testing may more accurately identify cardiovascular risk than LDL or non-HDL cholesterol, and guiding cholesterol-lowering treatment with apoB could prevent more heart attacks and strokes at a cost-effective rate, based on a large lifetime simulation of 250,000 adults and intensified therapy with statins and ezetimibe.




